Other biomarkers such as monocyte chemotactic protein 1 [47], ceruloplasmin [48], adiponectin [49], and kidney injury molecule 1 [50] were also verified to be valuable biomarkers in the diagnosis and monitoring of LN. Here, CCL2 is linked to lobular neoplasia.